"Just because it was faster doesn't mean that there's been any sacrifice for safety," said Rimland, who is now in her fourth year at the UNC School of Medicine and applying for residency.
She said in the spring she was shut out of rotations because of the pandemic. Feeling hopeless, Rimland decided she could give back in her own way by enrolling in a local Pfizer vaccine trial with her husband.
They're thrilled to see the U.S. government advisory panel endorse the widespread use of Pfizer's COVID-19 vaccine on Thursday. She says it's a huge step forward.
RELATED: Advisory panel endorses widespread use of Pfizer COVID-19 vaccine in US
"It's a testament to what we can do and accomplish when we put so much money and science research into accomplishing a singular goal," Casey said.
During the trial, participants are either given a placebo or a trial of the vaccine. Rimland believes she got a placebo while her husband got the actual vaccine.
After Cohen's second round, he had a fever of 100 and slight chills but it went away entirely after that. Rimland said she had no symptoms the second time -- not even a sore arm.
"I wanted to be able to help others," Aaron said. "To be able to have this vaccine come: I've told some people I'm really looking forward to hugging my parents again."
Should the Food and Drug Administration sign off on the expert committee's recommendation, the first 85,800 doses of the vaccine should arrive in North Carolina next week.
Duke University Hospital, UNC Medical Center, WakeMed Raleigh, Rex Hospital and Cape Fear Valley Medical Center will get more than 2,900 doses of the vaccine.
The doses count for just one round of the vaccine.
Have questions about the COVID-19 vaccine? Send them to us here